This stepwise escalation principle mirrors the approach used for licensed medicines such as semaglutide (Wegovy, UK SmPC available via the electronic Medicines Compendium) and tirzepatide (Mounjaro, UK SmPC available via the electronic Medicines Compendium), both of which are approved by the MHRA and recommended within relevant NICE guidance for specific indications
It is clear that the early integration of engagement strategies can lead to devices that resonate with users as tools for health empowerment
For example, one early protocol for substance use disorders employed 500-1,000 mg of NAD+ per day delivered by slow intravenous infusion over several consecutive days
Why affordability is a long-term concern Weight management protocols frequently recommend indefinite GLP-1 therapy
In one 56-week double-blind trial, participants taking 3 mg of liraglutide lost between 5%10% of their body weight
Our bodies produce semaglutide from GLP1, a modified molecule